Filing Details
- Accession Number:
- 0001415889-25-005730
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-26 18:52:05
- Reporting Period:
- 2024-06-13
- Filing Date:
- 2025-02-26
- Accepted Time:
- 2025-02-26 18:52:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1427925 | Talphera Inc. | TLPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2040805 | Shakil Aslam | C/O Talphera, Inc. 1850 Gateway Drive, Suite 175 San Mateo CA 94404 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-06-13 | 695 | $0.98 | 32,695 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2024-06-14 | 5,000 | $1.07 | 37,695 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Price reported is a weighted-average sales price. The shares were purchased at prices ranging from $1.07 to $1.08. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.